Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Rosmarin

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
International Journal of Dermatology|June 7, 2018
JAK-STAT signaling pathway inhibition: a role for treatment of discoid lupus erythematosus and dermatomyositisJared S Kahn, Sandhya Chowdary Deverapalli, David M Rosmarin
Journal of the American Academy of Dermatology|January 17, 2007
Toxic epidermal necrolysisFrederick A Pereira, Adarsh Vijay Mudgil, David M Rosmarin
Journal of the American Academy of Dermatology|November 26, 2009
Cyclosporine and psoriasis: 2008 National Psoriasis Foundation Consensus ConferenceDavid M Rosmarin, Mark Lebwohl, Boni E Elewski, et al.
Dermatology Online Journal|July 10, 2015
Repigmentation of hair following adalimumab therapySuzanne J Tintle, Tushar S Dabade, Robert A Kalish, et al.
Plos One|May 6, 2009
Diversity of 23S rRNA genes within individual prokaryotic genomesAnna Pei, Carlos W Nossa, Pooja Chokshi, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 8, 2012
Attachment of Chlamydia trachomatis L2 to host cells requires sulfationDavid M Rosmarin, Jan E Carette, Andrew J Olive, et al.
JAAD International|January 5, 2026
Utilization and predictors of use of immunomodulators for atopic dermatitis: A cohort studyPriyanka Anand, Arash Mostaghimi, Robert Glynn, et al.
JAMA Dermatology|January 21, 2026
Risk of Acne in Patients With Atopic Dermatitis Starting a JAK Inhibitor vs Th2 Cytokine InhibitorMaria C Schneeweiss, Richard Wyss, Priyanka Anand, et al.
The Journal of Investigative Dermatology|October 3, 2024
A Scalable Approach to Assess the Safety of Recently Marketed Systemic Treatments for Atopic Dermatitis in Clinical Practice: First Analysis Cycle of a Sequential Monitoring SystemMaria C Schneeweiss, Robert J Glynn, Richard Wyss, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2013
Intercellular trafficking of the nuclear oncoprotein DEKAnjan K Saha, Ferdinand Kappes, Amruta Mundade, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
International Journal of Dermatology|June 7, 2018
JAK-STAT signaling pathway inhibition: a role for treatment of discoid lupus erythematosus and dermatomyositisJared S Kahn, Sandhya Chowdary Deverapalli, David M Rosmarin
Journal of the American Academy of Dermatology|January 17, 2007
Toxic epidermal necrolysisFrederick A Pereira, Adarsh Vijay Mudgil, David M Rosmarin
Journal of the American Academy of Dermatology|November 26, 2009
Cyclosporine and psoriasis: 2008 National Psoriasis Foundation Consensus ConferenceDavid M Rosmarin, Mark Lebwohl, Boni E Elewski, et al.
Dermatology Online Journal|July 10, 2015
Repigmentation of hair following adalimumab therapySuzanne J Tintle, Tushar S Dabade, Robert A Kalish, et al.
Plos One|May 6, 2009
Diversity of 23S rRNA genes within individual prokaryotic genomesAnna Pei, Carlos W Nossa, Pooja Chokshi, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 8, 2012
Attachment of Chlamydia trachomatis L2 to host cells requires sulfationDavid M Rosmarin, Jan E Carette, Andrew J Olive, et al.
JAAD International|January 5, 2026
Utilization and predictors of use of immunomodulators for atopic dermatitis: A cohort studyPriyanka Anand, Arash Mostaghimi, Robert Glynn, et al.
JAMA Dermatology|January 21, 2026
Risk of Acne in Patients With Atopic Dermatitis Starting a JAK Inhibitor vs Th2 Cytokine InhibitorMaria C Schneeweiss, Richard Wyss, Priyanka Anand, et al.
The Journal of Investigative Dermatology|October 3, 2024
A Scalable Approach to Assess the Safety of Recently Marketed Systemic Treatments for Atopic Dermatitis in Clinical Practice: First Analysis Cycle of a Sequential Monitoring SystemMaria C Schneeweiss, Robert J Glynn, Richard Wyss, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2013
Intercellular trafficking of the nuclear oncoprotein DEKAnjan K Saha, Ferdinand Kappes, Amruta Mundade, et al.
Pageof 1